NDC codes

FDA NDC Directory
Product NDC (as listed)0254-1010Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00254-1010Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0254-1010-19002541010191 BOTTLE, DROPPER in 1 CARTON (0254-1010-19) / 30 mL in 1 BOTTLE, DROPPERMarketed from Jul 21, 2020

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Diazoxide
Generic name (nonproprietary)
diazoxide
Active ingredients
Diazoxide — 50 mg/mL
Dosage form
Suspension
Route
Oral
Labeler
Par Health USA, LLCNDC labeler code 0254
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 210799
Marketing start
Listing expires
Identifiers
Product ID 0254-1010_3e6f9f3d-926b-43e2-bc32-d941a5a2aaa5SPL ID 3e6f9f3d-926b-43e2-bc32-d941a5a2aaa5SPL set ID abe317a5-6c63-469c-89c8-9fedfe859c3dRxCUI 197593UNII O5CB12L4FNUPC 0302541010198

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400254101019 followed by a unit qualifier and the quantity

Package 00254-1010-19. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS & USAGE Diazoxide oral suspension is indicated for the management of hypoglycemia due to hyperinsulinism associated with the following conditions: Adults: Inoperable islet cell adenoma or carcinoma, or extrapancreatic malignancy. Infants and children: Leucine sensitivity, islet cell hyperplasia, nesidioblastosis, extrapancreatic malignancy, islet cell adenoma, or adenomatosis. Diazoxide oral suspension may be used preoperatively as a temporary measure, and postoperatively, if hypoglycemia persists. Diazoxide oral suspension should be used only after a diagnosis of hypoglycemia due to one of the above conditions has been definitely established. When other specific medical therapy …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0254-1010

What is NDC 0254-1010?
0254-1010 is the product NDC for Diazoxide, Diazoxide 50 mg/mL suspension, listed with the FDA by Par Health USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Diazoxide.
What is the active ingredient?
Diazoxide.
Who is the labeler?
Par Health USA, LLC, NDC labeler code 0254. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Diazoxide?
1 other product NDC are listed under this name. See all Diazoxide NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Diazoxide NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
DiazoxideDiazoxide 50 mg/mLSuspensionOrale5 Pharma, LLC13517-10013517-0100-30

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in